1,745
Views
1
CrossRef citations to date
0
Altmetric
Review

Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China

ORCID Icon
Article: 2146671 | Received 12 Sep 2022, Accepted 07 Nov 2022, Published online: 20 Nov 2022

References

  • Aljurf M, Weisdorf D, Alfraih F, et al. Worldwide network for blood & marrow transplantation (WBMT) special article, challenges facing emerging alternate donor registries. Bone Marrow Transplant. 2019;54(8):1–6. “
  • Xu LP, Lu PH, Wu DP, et al., Chinese Blood and Marrow Transplantation Registry Group. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese blood and marrow transplantation registry group. Bone Marrow Transplant. 2021;56(12):2940–2947.
  • Loren AW, Senapati S. Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants. Blood. 2019;134(9):746–760.
  • Xu L, Xu Z, Wang S, et al. Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study. Sci Bull. 2022;67(9):963–970.
  • Diesch-Furlanetto T, Rovó A, Galimard JE, et al. Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT pediatric diseases working party. Hum Reprod. 2021;36(11):2871–2882.
  • Balduzzi A, Dalle JH, Jahnukainen K, et al. Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the pediatric diseases working party of the EBMT and the international BFM study group. Bone Marrow Transplant. 2017;52(10):1406–1415. [J]
  • Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an international menopause society white paper. Climacteric. 2020;23(5):426–446.
  • Jadoul P, Donnez J. How does bone marrow transplantation affect ovarian function and fertility? Curr Opin Obstet Gynecol. 2012;24(3):164–171.
  • Zhang XH, Chen J, Han MZ, et al. The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol. 2021;14(1):145.
  • Anderson RA, Mitchell RT, Kelsey TW, et al. Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol. 2015;3(7):556–567.
  • De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111(1):101–108.
  • Zhu D, Chung H, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553–e564.
  • Kodama M, Komura H, Shimizu S, et al. Efficacy of hormone therapy for osteoporosis in adolescent girls after hematopoietic stem cell transplantation: a longitudinal study. Fertil Steril. 2011;95(2):731–735.
  • Ruan X. Chinese society of gynecological endocrinology affiliated to the international society of gynecological endocrinology guideline for ovarian tissue cryopreservation and transplantation. Gynecol Endocrinol. 2018;34(12):1005–1010.
  • Ruan X, Cheng J, Korell M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China. Climacteric 2020;23(6):574–580.
  • Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377(17):1657–1665.
  • Ruan X, Cheng J, Du J, et al. Analysis of fertility preservation by ovarian tissue cryopreservation in pediatric children in China. Front Endocrinol. 2022;13:930786.
  • Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency. Climacteric. 2022;25(4):421–424.
  • Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci. 2017;24(8):1111–1120.
  • Gellert SE, Pors SE, Kristensen SG, et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018;35(4):561–570.
  • Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–1033.
  • Liebenthron J, Reinsberg J, Van Der Ven K, et al. Serum anti-müllerian hormone concentration and follicle density throughout reproductive life and in different diseases—implications in fertility preservation. Hum Reprod. 2019;34(12):2513–2522.
  • Brodigan K, Kapadia M, Frazier AL, et al. Safety of surgical fertility preservation procedures in children prior to hematopoietic stem cell transplant. Transplant Cell Ther. 2021;27(8):696.e1–696.e4.
  • Bjelland EK, Wilkosz P, Tanbo TG, et al. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 survey). Hum Reprod. 2014;29(4):835–841.
  • Wilkosz P, Greggains GD, Tanbo TG, et al. Female reproductive decline is determined by remaining ovarian reserve and age. PLoS One. 2014;9(10):e108343.
  • Cheng J, Ruan X, Zhou Q, et al. How much total ovarian tissue can be removed without compromising ovarian function? an animal study. Gynecol Endocrinol. 2021;37(3):240–245.
  • Rowell EE, Corkum KS, Lautz TB, et al. Laparoscopic unilateral oophorectomy for ovarian tissue cryopreservation in children. J Pediatr Surg. 2019;54(3):543–549. [J]
  • Greve T, Clasen-Linde E, Andersen MT, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311–4316.
  • Anderson RA, Amant F, Braat D, et al., The ESHRE Guideline Group on Female Fertility Preservation. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
  • Dolmans M-M, Von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading european centers. Fertil Steril. 2021;115(5):1102–1115.
  • Poirot C, Fortin A, Dhédin N, et al. Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies. Haematologica. 2019;104(8):e360–e363.
  • Poirot C, Fortin A, Lacorte JM, et al. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation. Hum Reprod. 2019;34(6):1083–1094.
  • Shapira M, Dolmans M, Silber S, et al. Evaluation of ovarian tissue transplantation: results from three clinical centers. Fertil Steril. 2020;114(2):388–397.
  • Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–1410.
  • Dolmans M, Hossay C, Nguyen TYT, et al. Fertility preservation: how to preserve ovarian function in children, adolescents and adults. J Clin Med. 2021;10(22):5247.
  • Poirot C, Abirached F, Prades M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 2012;379(9815):588.
  • Ernst E, Kjaersgaard M, Birkebaek NH, et al. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013;49(4):911–914.
  • Demeestere I, Simon P, Dedeken L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood: figure 1. Hum Reprod. 2015;30(9):2107–2109.
  • Shapira M, Raanani H, Barshack I, et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109(1):48–53.
  • Sonmezer M, Ozkavukcu S, Sukur YE, et al. First pregnancy and live birth in Turkey following frozen-thawed ovarian tissue transplantation in a patient with acute lymphoblastic leukemia who underwent cord blood transplantation. J Assist Reprod Genet. 2020;37(8):2033–2043.
  • Silber SJ, Derosa M, Goldsmith S, et al. Cryopreservation and transplantation of ovarian tissue: results from one center in the USA. J Assist Reprod Genet. 2018;35(12):2205–2213.
  • Rodriguez-Wallberg KA, Milenkovic M, Papaikonomou K, et al. Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia – a case report. Haematologica. 2021;106(10):2783–2787.
  • Meirow D, Ra’Anani H, Shapira M, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016;106(2):467–474.
  • Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril. 2021;115(2):298–304.
  • Prasath EB, Chan MLH, Wong WHW, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29(2):276–278.
  • Segers I, Bardhi E, Mateizel I, et al. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. Hum Reprod. 2020;35(9):2026–2036.
  • Karavani G, Wasserzug-Pash P, Mordechai-Daniel T, et al. Age-Dependent in vitro maturation efficacy of human oocytes – is there an optimal age? Front Cell Dev Biol. 2021;9:667682.
  • Yin H, Jiang H, Kristensen SG, et al. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue. J Assist Reprod Genet. 2016;33(6):741–746.
  • Karavani G, Schachter-Safrai N, Revel A, et al. In vitro maturation rates in young premenarche patients. Fertil Steril. 2019;112(2):315–322.
  • Cohen Y, St-Onge-St-Hilaire A, Tannus S, et al. Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes. J Assist Reprod Genet. 2018;35(9):1683–1689.
  • Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110(43):17474–17479.
  • Telfer EE, Andersen CY. In vitro growth and maturation of primordial follicles and immature oocytes. Fertil Steril. 2021;115(5):1116–1125.
  • Cho E, Kim YY, Noh K, et al. A new possibility in fertility preservation: The artificial ovary. J Tissue Eng Regen Med. 2019;13(8):1294–1315.